Sort
85,873 grants matching “alzheimers”
The impact of hospital-based health information technology on health care quality and equity among patients with ADRD
$1,933,556Jie Chen · Univ Of Maryland, College Park · RF1 · FY2023 · AG
Human iPSC model of Cerebro-Vascular Interactions in ADRD
$1,931,965Sally Temple · Regenerative Research Foundation · R61 · FY2024 · NS
Neurobehavioral phenotyping of AD model mice using Motion Sequencing
$1,931,938Sandeep R Datta · Harvard Medical School · RF1 · FY2021 · AG
National Cell Respository for Alzheimer's Disease (NCRAD) (U24)
$1,931,890Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2014 · AG
National Social Life, Health and Aging Project
$1,931,859National Opinion Research Center · R01 · FY2005 · AG
Gene Therapy for Alzheimer's Disease
$1,931,174Salk Institute For Biological Studies · P01 · FY2003 · AG
Cell and molecular pathobiology of Alzheimer's Disease
$1,930,953Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2008 · AG
Commercialization, Adoption, Licensing and Manufacture of Exersides Refraints
$1,930,835Marie Pavini · Healthy Design, Ltd. Co. · SB1 · FY2022 · AG
Rush Alzheimer's Disease Core Center
$1,930,180David A Bennett · Rush University Medical Center · P30 · FY2007 · AG
Heat Shock Factors and Protein Misfolding Disease
$1,929,818Cagla Eroglu · Duke University · RF1 · FY2018 · AG
Impact of cerebral anatomical variations on cerebral perfusion, cerebrovascular reactivity, and biomarkers of cognitive decline
$1,929,374Jill Nicole Barnes · University Of Wisconsin-Madison · RF1 · FY2020 · NS
Mapping the vulnerable locus coeruleus pathways in aging and AD
$1,929,195Kwanghun Chung · Massachusetts Institute Of Technology · U01 · FY2024 · AG
ALZHEIMER'S DISEASE RESEARCH CENTER
$1,928,909Duke University · P50 · FY2001 · AG
Developing and evaluating new measures of family availability to provide care to people with dementia
$1,928,657Hwajung Choi · University Of Michigan At Ann Arbor · RF1 · FY2023 · AG
HABS-HD - Core B - Neuroimaging & Informatics Core
$1,928,633Arthur W Toga · University Of North Texas Hlth Sci Ctr · U19 · FY2022 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
$1,928,443Rima F Kaddurah-Daouk · Duke University · U01 · FY2022 · AG
Examining the role of glycosphingolipids in the progression and heterogeneity of synucleinopathies
$1,928,426Joseph R Mazzulli · Northwestern University At Chicago · RF1 · FY2019 · NS
A High Performance Research Image Repository (RIR) for the Washington University Center of High Performance Computing (CHPC)
$1,927,344Daniel Scott Marcus · Washington University · S10 · FY2021 · OD
Mayo Clinic Metabolomics Resource Core
$1,927,204K. Sreekumaran Nair · Mayo Clinic Rochester · U24 · FY2015 · DK
Clinical, Imaging, and Pathological Studies in the Oldest Old: The 90+ Study
$1,926,826Claudia H. Kawas · University Of California-Irvine · R01 · FY2017 · AG
Novel Therapeutics for Prion Diseases
$1,925,862Stanley B Prusiner · University Of California, San Francisco · P01 · FY2010 · AG
Functional and cell-type specific axonal pathways in the primate brain
$1,925,636R Clay Reid · Allen Institute · UG3 · FY2022 · MH
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease
$1,925,544Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Gene Therapy for Alzheimer's Disease
$1,925,461Salk Institute For Biological Studies · P01 · FY2002 · AG
Rush Alzheimer's Disease Core Center
$1,925,131David A Bennett · Rush University Medical Center · P30 · FY2006 · AG